Spyridon Theofilopoulos | Development Neurobiology | Best Researcher Award

Prof. Spyridon Theofilopoulos | Development Neurobiology | Best Researcher Award

Deree-The American College of Greece | Greece

AUTHOR PROFILE

Scopus

Orcid ID

Google Scholar

EARLY ACADEMIC PURSUITS

Spyridon Theofilopoulos embarked on his academic journey with a Bachelor of Science degree in Biochemistry from Imperial College of Science, Technology and Medicine, London, U.K. Following this, he pursued his passion for developmental neurobiology, obtaining his Ph.D. from the same institution. His doctoral research, supervised by Professor Henry F. Bradford, focused on neurotrophic factors in neurotransmitter phenotype determination and neuroprotection in the developing human and rat brain.

PROFESSIONAL ENDEAVORS

Dr. Theofilopoulos has held various academic positions internationally, demonstrating his expertise and commitment to the field. Noteworthy roles include his tenure as a Forskare (Senior Researcher/Assistant Professor) at the Karolinska Institute, Stockholm, Sweden, and as a Sêr Cymru II Rising Star fellow and Associate Professor at Swansea University Medical School, Swansea, U.K. Currently, he serves as a Professor and Instructor at the Biomedical Sciences Department of Deree-The American College of Greece, Athens, Greece.

CONTRIBUTIONS AND RESEARCH FOCUS ON DEVELOPMENT NEUROBIOLOGY

Dr. Theofilopoulos has made significant contributions to the field of developmental neurobiology, particularly in the areas of neuroprotection and neurotransmitter phenotype determination. His collaborative research with Teva Pharmaceuticals during his Ph.D. led to the development of Rasagiline, a novel compound for the treatment of Parkinson’s disease. Moreover, his work at Swansea University resulted in the establishment of the spin-off company CholesteniX Ltd, aiming to develop specific cholesterol metabolites for Amyotrophic Lateral Sclerosis therapy.

IMPACT AND INFLUENCE

Theofilopoulos's research has not only contributed to scientific advancements but has also garnered recognition and accolades. He has been invited as a speaker to numerous conferences and meetings, highlighting the impact of his work in the scientific community. Furthermore, his efforts were acknowledged with awards such as the "Outstanding Research and Innovation collaboration in Medicine, Health and Life Sciences" award in 2022.

ACADEMIC CITATIONS

Dr. Theofilopoulos's work has been cited extensively, indicating its relevance and impact in the scientific community. His publications have appeared in reputable journals, and he has served as a reviewer for various scientific publications, including Scientific Reports, eLife, and Frontiers in Cell and Developmental Biology.

LEGACY AND FUTURE CONTRIBUTIONS

Dr. Theofilopoulos's legacy lies in his dedication to advancing knowledge in developmental neurobiology and his commitment to mentoring the next generation of scientists. His research funding awards underscore the importance of his work and pave the way for future discoveries in the field. As he continues his academic journey, his contributions are expected to further shape the landscape of neuroscience research.

NOTABLE PUBLICATIONS

 

Xiaohu Ren | Metabolic disorders and their genetic basis | Best Researcher Award

Prof Dr. Xiaohu Ren | Metabolic disorders and their genetic basis | Best Researcher Award

Shenzhen Center for Disease Control and Prevention | China

Author Profile

Scopus

Orcid ID

EARLY ACADEMIC PURSUITS:

Dr. Xiaohu Ren commenced his academic journey with a Bachelor of Science in Biological Sciences from Shenzhen University (2005-2009), followed by a Master of Science in Biochemistry and Molecular Biology (2009-2012) from the same institution. Subsequently, he pursued a Ph.D. in Health Toxicology at Southern Medical University (2012-2015), where he laid the foundation for his research expertise in the field of toxicology.

PROFESSIONAL ENDEAVORS:

Since 2015, Dr. Ren has served as an Associate Chief Physician and Assistant Researcher at the Modern Toxicology Laboratory, Shenzhen Center for Disease Control and Prevention (CDC). Prior to this, he contributed as a Postdoctoral Researcher at the Shenzhen CDC from 2015 to 2017. These roles have provided him with ample opportunities to delve into the intricacies of environmental pollutants and occupational toxicants research.

CONTRIBUTIONS AND RESEARCH FOCUS ON METABOLIC DISORDERS AND THEIR GENETIC BASIS:

Dr. Ren's research endeavors have predominantly revolved around unraveling the molecular mechanisms underlying the damage inflicted on the human body by toxic substances. His expertise spans various analytical techniques, including proteomics, untargeted lipidomics, metabolomics, and cell phenotyping. Noteworthy among his contributions are the establishment of several toxicological testing and analysis methodologies, which have significantly advanced the field.

IMPACT AND INFLUENCE:

As an active member of numerous toxicological societies and committees in China, Dr. Ren has played a pivotal role in shaping the discourse surrounding toxicology research in the country. His work has garnered attention both nationally and internationally, contributing to the broader understanding of environmental health and toxicology.

ACADEMIC CITATIONS:

Dr. Ren's research findings have been cited extensively in the academic community, attesting to the significance and relevance of his contributions to the field. His publications have enriched the scientific literature on DNA repair pathways affected by environmental toxicants and carcinogenesis, shedding light on critical aspects of human health and disease.

LEGACY AND FUTURE CONTRIBUTIONS:

With a solid foundation established through years of academic pursuit and professional engagement, Dr. Xiaohu Ren continues to be a driving force in toxicology research. His legacy encompasses a body of work that has not only advanced scientific knowledge but also contributed to the development of practical solutions for mitigating the adverse effects of environmental pollutants. Moving forward, Dr. Ren remains committed to furthering his research agenda, with a focus on addressing emerging challenges in the field and making lasting contributions to public health and environmental well-being.

Notable Publications

Zafran Khan | Tuberculosis Researcher | Editorial Board Member

Mr. Zafran Khan | Tuberculosis | Editorial Board Member

University of Calgary | Pakisthan

Author Profile

Google Scholar

Orcid ID

EARLY ACADEMIC PURSUITS:

ZAFRAN KHAN initiated his academic journey at the University of Swat (UOS) in Swat, Pakistan, where he pursued a Bachelor of Science (Hons) in Microbiology from 2012 to 2016. During this period, he conducted research on the "Incidence of HCV in the general population of District Swat, Pakistan," showcasing an early interest in infectious diseases and molecular biology.

PROFESSIONAL ENDEAVORS:

Following his undergraduate studies, ZAFRAN KHAN ventured into higher education at the University of Chinese Academy of Sciences (UCAS) in Beijing, China. Here, he enrolled as a Master student in Biochemistry and Molecular Biology from September 2018 to August 2019. His coursework covered diverse topics, including Genomics, Immunology, Biochemistry, and Molecular Biology, laying a solid foundation for his subsequent research pursuits.

CONTRIBUTIONS AND RESEARCH FOCUS ON TUBERCULOSIS

ZAFRAN KHAN's notable research contributions are evident during his tenure as a Master's Full-time Research Candidate at the State Key Laboratory of Respiratory Infectious Disease (GIBH) in Guangzhou, China, from August 2019 to August 2021. His primary research focus encompassed Mycobacterium tuberculosis resistance mechanisms, novel drug targets, docking, molecular dynamic simulation, and vaccine and drug designing. Noteworthy projects include the identification of resistance mechanisms associated with prothionamide and amikacin in Mycobacterium tuberculosis clinical isolates.

IMPACT AND INFLUENCE:

ZAFRAN KHAN's work holds significant implications for understanding and combating tuberculosis, a global health concern. His efforts in exploring unexplored resistance mechanisms and conducting molecular detection of anti-tubercular resistance in clinical isolates contribute to the broader scientific community's knowledge base. The impact of his research extends beyond borders, as evidenced by his involvement in international conferences and workshops.

ACADEMIC CITES:

ZAFRAN KHAN's academic journey is marked by a commitment to excellence, exemplified by his active participation in international conferences and workshops. This exposure has likely contributed to his knowledge enrichment and the incorporation of global perspectives into his research.

LEGACY AND FUTURE CONTRIBUTIONS:

ZAFRAN KHAN has established a legacy of dedication and proficiency in the field of Microbiology and Molecular Biology. His early research on HCV in Swat and subsequent work on tuberculosis resistance mechanisms showcase a commitment to addressing critical health challenges. As he progresses in his academic and research journey, ZAFRAN KHAN is poised to make further contributions to the scientific community, leaving a lasting legacy in the realm of infectious diseases and immunity.

Notable Publications

Guillain-Barre syndrome: An autoimmune disorder post-COVID-19 vaccination?  2022(9)

Cold stress-induced seed germination and biosynthesis of polyphenolics content in medicinally important Brassica rapa 2022(8)

Chimeric antigen receptor T cell structure, its manufacturing, and related toxicities; a comprehensive review 2022(7)

 

Akshay Bhuvaneswari Ramakrishnan | Bioinformatics | Young Scientist Award

Mr. Akshay Bhuvaneswari Ramakrishnan | Bioinformatics | Young Scientist Award

Sastra University | India

Author Profile 

Scopus

EARLY ACADEMIC PURSUITS

Akshay B R embarked on his academic journey by pursuing a Bachelor of Technology in Computer Science at Shanmugha Arts, Science, Technology and Research Academy, where he maintained a commendable CGPA of 7.4. Prior to this, he completed his high school education at Maharishi Vidya Mandir Senior Secondary School in Chennai, achieving a notable 72% in 2020.

PROFESSIONAL ENDEAVORS

Demonstrating a commitment to technological advancements, Akshay has been an influential Student Ambassador for Intel Since 2022. In this role, he effectively represented Intel Corporation, promoting the open-source oneAPI platform through various activities and events. Additionally, he has contributed significantly as a Research Assistant at the National Institute of Technology, engaging in research activities related to Advance Driver Assistance System (ADAS) and Brain Tumor Segmentation.

CONTRIBUTIONS AND RESEARCH FOCUS ON BIOINFORMATICS

Akshay's research focus has been on critical issues such as ADAS and Brain Tumor Segmentation. As a Research Assistant, he actively participated in literature reviews, data collection, and analysis. His contribution to developing research papers and presentations underscores his dedication to advancing knowledge in these domains.

IMPACT AND INFLUENCE

As a Clinical Data Analyst at Maruthi Hospital, Akshay applied his analytical skills to interpret clinical data, identify trends, and improve patient care. His work involved collaborating with healthcare professionals to implement data-driven solutions, showcasing a tangible impact on healthcare decision-making.

ACADEMIC CITES

Akshay's academic prowess is evident in his achievements, highlighted by his notable projects. The projects include an IoT-Based Epilepsy Detection Device, a Power BI Sales Dashboard for Zomato, and significant contributions to the field of ophthalmological disease classification and brain tumor detection using CNN architectures.

LEGACY AND FUTURE CONTRIBUTIONS

Akshay leaves a legacy of academic excellence and impactful contributions to technology and healthcare. His future contributions are anticipated to further shape the intersection of computer science, healthcare, and research, as evidenced by his continuous pursuit of knowledge and active involvement in cutting-edge projects.

Notable Publications

Optimizing brain tumor classification with hybrid CNN architecture: Balancing accuracy and efficiency through oneAPI optimization 2024